1. Advances and Opportunities to Address Co-Infections: CMV Retinitis and Hepatitis C IAS 2013 Sunday 30 July

2. Why Co-Infections…? Co-infections remain important despite the success of ART roll out Late presenters - CMV Important co-infection even in face of ART - HCV Need for additional political will and funding Testing and treatment often not supported Few guidelines Regional importance Key opportunities CMV: Potential for decentralization of screening, diagnosis and treatment HCV: Potential for paradigm shifting pipeline regimens

3. Goals: CMV and HCV Examine burden Explore challenges in diagnosis and treatment Share MSF experience Highlight critical and timely opportunities to improve access to diagnosis, treatment and care

4. Agenda CMV Retinitis – the neglected co-infection Khin Nyein Chan, Nathan Ford Peter Saranchuk Arax Bozadjian **Respondant: Dr. Rewari Hepatitis C – Increasing recognition of importance Nicolas Durier Isabelle Andrieux-Meyer Manica Balasegaram **Respondant: Shiba Phurailatpam